Non-profit versus For-profit Medical Institutions and the Commercialization of Invention
|Title||Non-profit versus For-profit Medical Institutions and the Commercialization of Invention|
|Author||Catherine Kirby, Ed Egan|
|© edegan.com, 2016|
- Grant Data
- Clinical Trial Data
- Our data on Medical Centers
- Core Patent Data
- Patent Assignment Data
Clinical trials are crucial for many biotech/life-science innovations. They generally can not take place at the same institution that conceived the invention. Clinical trials can take place at non-profit or for-profit institutions. Invention can take place in for-profit/non-profit incumbents, startups, academia, etc. Invention may be funded by grants and may result (perhaps post phase 2 trial) in patents. For-profit institutions that conduct clinical trials have market-based incentives to align the innovation paths of those they work with, non-profits do not. We should therefore expect to see startups and for-profit incumbents engage more with for-profit clinical trial institutions. We could identify causality on the for/non-profit effect if some clinical trial institutions switch status.
Measures of the relationship
- Patents can (and frequently do) have more than one assignee at a time. Assignment also changes as patents are sold or exclusively licensed (as well as for other reason). Patents with joint assignment or sequential assignment are relevant.
- Clinical trials have one or more sponsors and one or more locations. Clinical trials jointly sponsored by a startup and a medical center facility or sponsored by a startup and then located at a medical center facility are relevant.
- NIH grants have one or more recipients as well as associated patents and trials
Catherine matched patents, grants, and clinical trials to Medical Centers. She's going to prototype this as a report for the Medical Centers and Grants project.